Stanford Diagnosis, New Plan
My Stanford oncologist called at about 5pm on Friday; he received a preliminary report from the Stanford pathologist and he knew we wanted to hear any news as soon as he had it. They confirmed his suspicion: my lymphoma is Splenic Marginal Zone Lymphoma (SMZL). It is rare (less than 2% of non-Hodgkin lymphomas) and indolent (meaning slow growing). It is usually found in much older people. I guess I have a knack for finding the unusual. How were they so wrong about the first diagnosis you might ask, as we have? The rarity of SMZL is one factor. We also read that under a microscope SMZL can look like other lymphomas, such as DBCL. We went to Stanford specifically because these features can lead to misdiagnosis. A common first line treatment for SMZL is a splenectomy. Since my spleen is the size of Jupiter (that’s just a rough estimate - 😁), that’s where we are headed next. A large portion of the cancerous cells are in the spleen, so removing that will resu...